Hit-to-Lead


Weill Medical College of Cornell University, NIAID, NIH, DHHS
The Broad Institute
GlaxoSmithKline
Rutgers University
TB Alliance, University of Auckland
TB Alliance, University of Auckland
Aston University, University of Birmingham, Tres Cantos GSK
Colorado State University
University of Illinois at Chicago, Myongji University
Texas A&M University
University of Illinois at Chicago
GlaxoSmithKline, TB Alliance
Lilly TB Drug Discovery Initative
TB Alliance, Sanofi
SPRINT-TB (National University of Singapore)
SPRINT-TB (National University of Singapore)

Lead Optimization


GlaxoSmithKline, Rutgers, The State University of New Jersey
CSIR-Institute for Microbial Technology (IMTech), Johnson & Johnson
GlaxoSmithKline
Institute of Materia Medica
Texas A&M University
São Paulo State University (UNESP)
Calibr, The Scripps Research Institute
TB Alliance
GlaxoSmithKline, Anacor Pharmaceuticals
SPRINT TB (National University of Singapore)
Kanury Rao, Sundeep Duggar
GlaxoSmithKline, TB Alliance
Sequella
Sanofi , TB Alliance
TB Alliance/Yonsei University
SPRINT-TB (National University of Singapore)
SPRINT-TB (National University of Singapore)
TB Alliance, Sanofi

Pre-Clinical (Non-GLP)


GlaxoSmithKline
Guangzhou Institute of Respiratory Medicine Company Limited
Institute of Microbial Chemistry (BIKAKEN), Tokyo, Japan, Lilly TB Drug Discovery Initiative, NIAID, IDRI, Lilly, YourEncore